Julie Burek's Net Worth
$350 Thousand
Who is Julie Burek?
Julie Burek does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Voyager Therapeutics, Inc..
SEC CIK
Julie Burek's CIK is 0001894915
Past Insider Trading and Trends
2021 was Julie Burek's most active year for acquiring shares with 3 total transactions. Julie Burek's most active month to acquire stocks was the month of December. 2022 was Julie Burek's most active year for disposing of shares, totalling 6 transactions. Julie Burek's most active month to dispose stocks was the month of December. 2021 saw Julie Burek paying a total of $7,044.90 for 41,563 shares, this is the most they've acquired in one year. In 2022 Julie Burek cashed out on 7,127 shares for a total of $35,465.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Voyager Therapeutics, Inc. (VYGR) Snapshot price: $6.13
VP, FinanceJulie Burek owns 52,458 units of Common Stock which is worth $321,567.54. In the year 2021 Julie Burek filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.81% | -2.65K |
$8.29 | -$21,972.30 | 52.46K |
Scheduled
|
Mar 21
| ||
Form 4
| -1.41% | -789.00 |
$3.55 | -$2,800.95 | 55.11K |
Scheduled
|
Feb 17
| ||
Form 4
| -0.64% | -361.00 |
$3.36 | -$1,212.96 | 55.9K |
Scheduled
|
Feb 11
| ||
Form 4
| +21.62% | 10K |
—
|
—
| 56.26K |
Jan 13
| |||
Form 4
| -0.57% | -265.00 |
$2.58 | -$2,434.29 | 46.26K |
Scheduled
|
Dec 31 - Jan 12
| ||
Form 4
| +40.88% | 13.5K |
—
|
—
| 46.52K |
Nov 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||